findmyKOL
Clinical trialNCT01361464CompletedPhase 2Interventional

Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia

SponsorNational Cancer Institute (NCI)Enrollment21Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With MaturationAdult Acute Myeloid Leukemia With Minimal Differentiation+10 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Blood and Marrow Transplant Group of Georgia

    Atlanta, Georgia, United States

  • Emory University/winship Cancer Institute

    Atlanta, Georgia, United States

  • Johns Hopkins University/sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Weill Medical College of Cornell University

    New York, New York, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2011
Primary completion
30 Nov 2014
Completion
30 Nov 2014
Last update posted
8 Apr 2015
Registered enrollment
21
Registry id
NCT01361464

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.